Glenmark launches drug for treating type 2 diabetes

Glenmark Pharmaceuticals has launched the first triple fixed-dose combination (FDC) Teneligliptin with Pioglitazone and Metformin in India for treating uncontrolled type 2 diabetes.

Related Keywords

India ,Alok Malik ,Glenmark Pharmaceuticals ,Dipeptidyl Peptidase ,Executive Vice President ,Business Head ,India Formulations ,Glenmark ,Aunches ,Drug ,Or ,Reating ,Type , ,Diabetes ,News ,Ews India ,